Raho G - Search Results

1

Functional domains of the ATPase inhibitor protein from bovine heart mitochondria.

Zanotti F, Raho G, Vuolo R, Gaballo A, Papa F, Papa S. Zanotti F, et al. Among authors: raho g. FEBS Lett. 2000 Sep 29;482(1-2):163-6. doi: 10.1016/s0014-5793(00)02055-x. FEBS Lett. 2000. PMID: 11018542 Free article.

2

Inhibitory and anchoring domains in the ATPase inhibitor protein IF1 of bovine heart mitochondrial ATP synthase.

Zanotti F, Raho G, Gaballo A, Papa S. Zanotti F, et al. Among authors: raho g. J Bioenerg Biomembr. 2004 Oct;36(5):447-57. doi: 10.1023/B:JOBB.0000047327.68173.9b. J Bioenerg Biomembr. 2004. PMID: 15534392

3

Disulfide cross-linking of subunits F(1)-gamma and F(0)I-PVP(b) results in asymmetric effects on proton translocation in the mitochondrial ATP synthase.

Gaballo A, Zanotti F, Raho G, Papa S. Gaballo A, et al. Among authors: raho g. FEBS Lett. 1999 Dec 10;463(1-2):7-11. doi: 10.1016/s0014-5793(99)01593-8. FEBS Lett. 1999. PMID: 10601627 Free article.

4

F1 and F0 connections in the bovine mitochondrial ATP synthase: the role of the of alpha subunit N-terminus, oligomycin-sensitivity conferring protein (OCSP) and subunit d.

Xu T, Zanotti F, Gaballo A, Raho G, Papa S. Xu T, et al. Among authors: raho g. Eur J Biochem. 2000 Jul;267(14):4445-55. doi: 10.1046/j.1432-1327.2000.01492.x. Eur J Biochem. 2000. PMID: 10880968 Free article.

5

Over-expression of Mn-superoxide dismutase as a marker of oxidative stress in lesional skin of chronic idiopathic urticaria.

Raho G, Cassano N, D'Argento V, Vena GA, Zanotti F. Raho G, et al. Clin Exp Dermatol. 2003 May;28(3):318-20. doi: 10.1046/j.1365-2230.2003.01264.x. Clin Exp Dermatol. 2003. PMID: 12780723

6

Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.

Cassano N, Raho G, Filieri M, D'Argento V, Amoruso A, Filotico R, Vena GA. Cassano N, et al. Among authors: raho g. Int J Dermatol. 2006 Apr;45(4):394-6. doi: 10.1111/j.1365-4632.2006.02467.x. Int J Dermatol. 2006. PMID: 16650165 Clinical Trial.

7

Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study Group.

Cassano N, Loconsole F, Miracapillo A, Travaglini M, Digiuseppe MD, Congedo M, Galluccio A, Buquicchio R, Mastrandrea V, Filieri M, Raho G, Pezza M, Vena GA. Cassano N, et al. Among authors: raho g. Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):797-802. doi: 10.1177/039463201002300314. Int J Immunopathol Pharmacol. 2010. PMID: 20943050 Free article. Clinical Trial.

8

Influence of infliximab on keratinocyte apoptosis in psoriasis patients.

Raho G, Vena GA, Bizzoca A, Cassano N, Garofalo E, Congedo M, Gennarini G. Raho G, et al. Immunopharmacol Immunotoxicol. 2011 Mar;33(1):227-31. doi: 10.3109/08923973.2010.487068. Epub 2010 May 27. Immunopharmacol Immunotoxicol. 2011. PMID: 20507213

9

The burden of moderate to severe psoriasis: an overview.

Raho G, Koleva DM, Garattini L, Naldi L. Raho G, et al. Pharmacoeconomics. 2012 Nov 1;30(11):1005-13. doi: 10.2165/11591580-000000000-00000. Pharmacoeconomics. 2012. PMID: 22994598 Review.

10

Emerging drugs for psoriasis.

Naldi L, Raho G. Naldi L, et al. Among authors: raho g. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. doi: 10.1517/14728210902771334. Expert Opin Emerg Drugs. 2009. PMID: 19249988 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters